This method makes use of melatonin receptor antagonists such as luzindole and/or K-185 to reverse the inhibitory effect of melatonin.
Existing Luzindole Patents cover pathological states. Current research on melatonin and cognition primarily uses NOCTURNAL rodents.
This invention demonstrates for the first time that luzindole has the potential to improve long-term memory of healthy persons when learning takes place during the night.
Students, Shift Workers, Pilots - Military and Commercial, Any looking for an edge.